Greenleaf Medical - Logo

About us

Christer Köhler / Chairman

Former Professor of Neuroscience with some 30 years of experience from leading positions in the global pharmaceutical industry, including Roche and AstraZeneca. As Vice President within global pharma R&D, has managed investments into the discovery and development of new medicines in different therapeutic areas.

Brings a strong focus on R & D as well as regulatory and compliance issues to the GLM business.

Charlotte Erlanson-Albertsson / Board Member

Professor of Medical and Physiological Chemistry, Lund University. 30 years of experience in medical science on appetite regulation and energy balance, with emphasis on the effects of palatable food containing sugar, fat and salt on these parameters. The research has focused on the role of the intestine and its signals to the brain to understand the reason for overeating in modern society and thereby find methods to defeat this. Swedish Medical Research Council, Vinnova, FORMAS and Royal Physiographic Society have supported the research during several years. In this way Thylakoids and Appethyl were found as efficient tools against cravings of palatable food. Working experience from well-known international laboratories in France, Switzerland and USA. Produced 150 scientific articles, several text-books and popular science books on healthy eating.

Stefan Wilhelmson / Board Member

Managing Director and partner – AMENEA AB, Alternative Investment Fund Manager (AIFMD). Investor and Board member of the leading Nordic independent food supplier within organic food and food for lachtos- and gluten intolerance 2004-2016.  15 years of experience in private equity and almost 30 years in the financial sector. Former Managing Director and partner of Auda International and before that various management positions with SEB/Enskilda and Unibank/Nordea, primarily within Corporate Finance/Banking and Investment Management. Master of Science in Business Administration and Bachelor of Science in Behavioural Science at Lund University.

Hans Dyster-Aas / Board Member

25 years of experience from the financial industry in various leading positions at SEB, Carnegie and NGM. Currently running a private holding company with a long tradition from investing in early stage companies. Currently a board member in several of them. BSc of business administration and economics at the Lund University.

Prof. Martin Schalling / Board Member

An MD graduate from the Karolinska Institutet, Martin Schalling holds a PhD in Molecular Biology. He was an EMBO and a Fulbright Scholar while at MIT and is affiliated with UCSD. He has a three decades-long track record of success in science, with more than 20 publications in journals with high impact factor (over 10), 260 papers/manuscripts and 120 abstracts to meetings and conferences, and a number of research grants from Swedish Research Council, Karolinska Hospital and Institutet, various foundations and industry (support for exploratory research). Professor of Medical Genetics, Mr. Schalling is currently heading the Neurogenetics group at Karolinska Institutet and serves on the steering group of the Center for Molecular Medicine, Swedish Twin Registry as well as other organizations. His professional engagements include: Advisory Board at Max Planch Institute, Group leadership at Center for Molecular Medicine (KI), co-chair of a world congress and Editorial Boards of several journals. He is the coordinator for Karolinska Institutet and Mayo Clinic collaborative platform. Professor Schalling has been involved in entrepreneurial efforts in the biotech as well as the nutraceutical industry for the past decade.

Back to Top ⇑

Greenleaf Medical - LogoCopyright 2017 Greenleaf Medical AB. All rights reserved.